phenytoin has been researched along with Mucopolysaccharidoses in 2 studies
Mucopolysaccharidoses: Group of lysosomal storage diseases each caused by an inherited deficiency of an enzyme involved in the degradation of glycosaminoglycans (mucopolysaccharides). The diseases are progressive and often display a wide spectrum of clinical severity within one enzyme deficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koskiniemi, M | 1 |
| Goldstein, DA | 1 |
| Clarke, JT | 1 |
| Soldin, SJ | 1 |
2 other studies available for phenytoin and Mucopolysaccharidoses
| Article | Year |
|---|---|
Findings in routine laboratory examination in progressive myoclonus epilepsy.
Topics: Adolescent; Adult; Age Factors; Blood Glucose; Blood Proteins; Cerebrospinal Fluid Proteins; Child; | 1975 |
Volume of distribution of phenytoin not altered in storage disease.
Topics: Adolescent; Adult; Child; Humans; Kinetics; Mucopolysaccharidoses; Phenytoin | 1987 |